KFDA announced final review against bio test institutes.

Published: 2006-10-02 07:00:00

Updated: 2006-10-02 07:00:00

The KFDA announced the final review report on the bio equivalency tests on Sept. 28 that the total 75 products were found of its data discordance and therefore penalized with a registration cancellation and a re-test was ordered for the total 576 products that were unable to find its data conform...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK